N-(2-(5-(phenoxymethyl)isoxazol-3-yloxy)ethyl)cyclobutanamine

ID: ALA4743313

PubChem CID: 162645680

Max Phase: Preclinical

Molecular Formula: C16H20N2O3

Molecular Weight: 288.35

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1ccc(OCc2cc(OCCNC3CCC3)no2)cc1

Standard InChI:  InChI=1S/C16H20N2O3/c1-2-7-14(8-3-1)20-12-15-11-16(18-21-15)19-10-9-17-13-5-4-6-13/h1-3,7-8,11,13,17H,4-6,9-10,12H2

Standard InChI Key:  BGNLRKAAEJHUCK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   14.1418   -7.9335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9668   -7.9335    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2236   -7.1494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5543   -6.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8892   -7.1494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1045   -6.8947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4917   -7.4471    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7069   -7.1925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5403   -6.3841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7563   -6.1294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1425   -6.6819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3179   -7.4925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1016   -7.7434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0086   -6.8954    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6209   -7.4484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4060   -7.1945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0183   -7.7474    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8032   -7.4935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5345   -7.8712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9101   -7.1366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1755   -6.7611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  3 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4743313

    ---

Associated Targets(Human)

SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SIGMAR1 Sigma-1 receptor (3326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tmem97 Sigma intracellular receptor 2 (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 288.35Molecular Weight (Monoisotopic): 288.1474AlogP: 2.77#Rotatable Bonds: 8
Polar Surface Area: 56.52Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.38CX LogP: 2.81CX LogD: 0.85
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.76Np Likeness Score: -1.26

References

1. Ye N,Qin W,Tian S,Xu Q,Wold EA,Zhou J,Zhen XC.  (2020)  Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.,  63  (24.0): [PMID:33111525] [10.1021/acs.jmedchem.0c01192]

Source